Skip to main content

Table 3 The results of uivariate analysis

From: The association between triglyceride glucose-body Mass Index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study

No. of available embryos

Statistics

β(95%CI), P value

TyG-BMI index

207.69 ± 40.37

-0.02 (-0.03, -0.01) < 0.0001

Duration of infertility(year)

3.29 ± 2.05

-0.10 (-0.24, 0.03) 0.133

BMI (kg/m2)

  

< 18.5

38 (3.93%)

0

18.5–25

547 (56.63%)

-0.35 (-1.78, 1.07) 0.626

25–30

282 (29.19%)

-1.39 (-2.86, 0.07) 0.063

≥ 30

99 (10.25%)

-2.71 (-4.33, -1.08) 0.001

AMH(ng/ml)

11.61 ± 5.45

0.14 (0.09, 0.19) < 0.0001

AFC

15.48 ± 4.96

0.40 (0.35, 0.45) < 0.0001

BASAL FSH (IU/L)

6.64 ± 2.02

-0.20 (-0.34, -0.06) 0.004

BASAL E2 (pg/ml)

49.07 ± 57.43

0.00 (-0.00, 0.01) 0.862

BASAL LH (IU/L)

7.63 ± 4.20

0.12 (0.06, 0.19) 0.0003

BASLA T (ng/dl)

0.75 ± 2.65

-0.02 (-0.12, 0.09) 0.757

Total Gn dose (IU)

1842.39 ± 648.48

-0.00 (-0.00, -0.00) < 0.0001

Starting dose of Gn (IU)

189.50 ± 36.14

-0.02 (-0.03, -0.01) < 0.0001

Duration of Gn (day)

9.25 ± 1.74

-0.21 (-0.37, -0.05) 0.011

  1. Data is represented as β(95%CI), P value
  2. Abbreviations: TyG-BMI index, triglyceride glucose-body mass index; BMI, body mass index;
  3. FSH, follicle-stimulating hormone; LH, luteinizing hormone; T, testosterone;
  4. AMH anti-müllerian hormone; AFC, antral follicle count; Gn, gonadotropin.